Treatment Registry
TR-0471 ActiveRecorded September 2, 2026

Compounded semaglutide

Sold by Royal Medical Center · Injection, vial · every compounded semaglutide record

What you actually pay

Per month

$67

Medication · Compounded GLP-1 program, starting price$67

Added from the figures recorded below.

Price

TermPer monthCharged today
Compounded GLP-1 program, starting price

Compounded GLP-1 Tirzepatide & Semaglutide Starting at $67 per month Includes all medications Includes supplies and injections Includes physician consultations and follow-ups Includes lab monitoring and adjustments

source

Per month$67Charged today$67
Visit Royal Medical Center

We earn nothing from this link. Royal Medical Center has no commercial arrangement with Treatment Registry, and its record here is kept to the same standard as every other.

History

One reading so far. A price history appears here after the next verification pass.

  • September 2, 2026Entry added to the register

Sourcing and terms

Not yet checked: pharmacy, states, prescriber, cancellation, membership and consult fee.

Notes

  1. 1. September 2, 2026A single 'starting at $67/month' price is published for a combined tirzepatide-and-semaglutide compounded program; the page does not break the price out per drug, so the same figure was recorded against both. No page found stating served states, prescriber synchronicity, cancellation terms, or a membership fee — checked the men's FAQ, women's FAQ, weight-loss page, and HIPAA policy without finding any of these.

Treatment Registry is an independent editorial record. It is not a government registry, a licensing body, or a certification. An entry means we recorded what a company published on a given date. It does not mean we recommend the program, and it does not mean the program is approved by anyone.

This record

Entry
TR-0471
Readings
1

Related records

What else Royal Medical Center sells

All Royal Medical Center programs and terms

Compounded semaglutide at a similar price

The records either side of this one in the recorded spread. Not a ranking, and not a recommendation — a position among 298 records of the same molecule.

Cite this entry

Treatment Registry. (2026). Royal Medical Center compounded semaglutide (TR-0471). Last verified September 2, 2026. Retrieved [your access date], from https://treatmentregistry.com/registry/TR-0471

Replace the bracket with the date you read it. Ours is the date we last checked the figures, which is a different thing and is given separately.